Rezk, R. | bioRxiv Science

bioRxiv2022

Differential response of patient-derived primary glioblastoma cells to metabolic and adhesion inhibitors

PurposeThis study aims to investigate Glioblastoma (GBM) cellular response to adhesion and metabolic inhibitors in the context of cells migration and cell-matrix adhesion properties. GBM is the most common incurable brain tumour. Decades of work into GBM chemical and molecular classification have identified mechanisms of drug resistance. Inhibitors targeting cancer cell migration and proliferation rarely take into consideration the heterogeneous migration property amongst cells, which may impact patients response to treatment. MethodsTissue samples were obtained from spatially distinct locations with different 5-aminolevulinic acid (5-ALA) fluorescent intensities, strong strongly fluorescent tumour cores, a weak fluorescent tumour rim, and nonfluorescent tumour margins. Samples were previously shown to be associated with different motility and adhesion properties. We tested tumour cells response to adhesion and metabolic inhibitors using metabolic assays. Cell survival was also monitored using time-lapse microscopy, while cultured on low-modulus polydimethylsiloxane representative of the stiffness of brain tissue. ResultsMetabolic viability assays, MTT and Cell Titer, showed substantial heterogeneity in drug potency. Highly fluorescent tumour core cells were significantly more resistant to an F0F1 ATP synthase inhibitor (Gboxin), and a FAK inhibitor (GSK2256098), and cell proliferation ceased post-treatment in vitro. Cells derived from non-fluorescent tumour margins exhibited higher potency for the ATP synthase inhibitor (Gboxin). However, cell proliferation persisted post-treatment. ConclusionOur study suggests that the adhesive and migration properties of cells account for the sensitivity to therapeutics in different regions of the tumour in individual patients and between patients with GBM.

neuroscience↗

bioRxiv2020

Spatial heterogeneity of cell-matrix adhesive forces predicts human glioblastoma migration

BackgroundGlioblastoma (GBM) is a highly aggressive incurable brain tumor. The main cause of mortality in GBM patients is the invasive rim of cells migrating away from the main tumor mass and invading healthy parts of the brain. Although motion is driven by forces, our current understanding of the physical factors involved in glioma infiltration remains limited. This study aims to investigate the adhesion properties within and between patients tumors on a cellular level and test whether these properties correlate with cell migration. MethodsNine tissue samples were taken from spatially separated sections during 5-aminolevulinic acid (5-ALA) fluorescence guided surgery. Navigated biopsy samples were collected from strongly fluorescent tumor cores, a weak fluorescent tumor rim, and non-fluorescent tumor margins. A microfluidics device was built to induce controlled shear forces to detach cells from monolayer cultures. Cells were cultured on low modulus polydimethylsiloxane representative of the stiffness of brain tissue. Cell migration and morphology were then obtained using time lapse microscopy. ResultsGBM cell populations from different tumor fractions of the same patient exhibited different migratory and adhesive behaviors. These differences were associated with sampling location and amount of 5-ALA fluorescence. Cells derived from weak- and non-fluorescent tumor tissue were smaller, adhered less well, and migrated quicker than cells derived from strongly fluorescent tumor mass. ConclusionGBM tumors are biomechanically heterogeneous. Selecting multiple populations and broad location sampling are therefore important to consider for drug testing. Key pointsGBM tumors are biomechanically heterogeneous GBM cell migration is inversely correlated with cell-matrix adhesion strength 5-ALA fluorescence intensity during surgery correlates with the motility properties of GBM cells Importance of the studyThis is the first study to compare single cell migration and cell-matrix adhesion strength of GBM, using cell lines derived from different tumors and from different regions within the same tumor. Not accounting for internal sampling location within each tumor obscures differences in cell morphology, motility and adhesion properties between patients. Peripherical and marginal tumor cells have different adhesion profiles and are highly migratory compared to those found in the core of the tumor. Aggressive regions of the tumor (highly motile) are linked to the spatial distribution of adhesion strength and are strongly associated with 5-ALA fluorescence intensity. Preclinical tests aimed at developing a treatment for GBM using anti-invasive drugs or adhesion inhibitors, would benefit from using cell lines derived from the tumor periphery (with low 5-ALA intensity) rather than cell lines derived from the tumor core.

biophysics↗